Archive | Melanoma In The News

Pembrolizumab Plus Reduced-dose Ipilimumab Safe in Advanced Melanoma

Patients with advanced melanoma may have good outcomes when treated with standard-dose pembrolizumab with 4 doses of reduced-dose ipilimumab, according to a study published in The Lancet Oncology.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Medicare, insurance beneficiaries have improved access to uveal melanoma test

Three important access milestones for DecisionDx-UM have been reached, Castle Biosciences announced in a press release.

Read the full story

Posted in Melanoma In The News, Information

Personalized Cancer Vaccines Demonstrate Potential in Melanoma Studies

NEW YORK (GenomeWeb) – A pair of new studies is pointing to the potential of personalized anti-cancer vaccine strategies in individuals with advanced melanoma.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Link between Parkinson’s and melanoma runs both ways

A study published this week in Mayo Clinic Proceedings confirms that Parkinson’s disease can, perhaps surprisingly, increase the risk of melanoma.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories